ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
13.36
+0.31 (2.38%)
At close: Jul 19, 2024, 4:00 PM
13.50
+0.14 (1.05%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
ADMA Biologics Employees
ADMA Biologics had 624 employees as of December 31, 2023. The number of employees increased by 7 or 1.13% compared to the previous year.
Employees
624
Change (1Y)
7
Growth (1Y)
1.13%
Revenue / Employee
$453,808
Profits / Employee
-$5,840
Market Cap
3.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 624 | 7 | 1.13% |
Dec 31, 2022 | 617 | 90 | 17.08% |
Dec 31, 2021 | 527 | 120 | 29.48% |
Dec 31, 2020 | 407 | 93 | 29.62% |
Dec 31, 2019 | 314 | -4 | -1.26% |
Dec 31, 2018 | 318 | 23 | 7.80% |
Dec 31, 2017 | 295 | 203 | 220.65% |
Dec 31, 2016 | 92 | 18 | 24.32% |
Dec 31, 2015 | 74 | 14 | 23.33% |
Dec 31, 2014 | 60 | 18 | 42.86% |
Dec 31, 2013 | 42 | 15 | 55.56% |
Dec 31, 2012 | 27 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
Oscar Health | 2,400 |
iRhythm Technologies | 2,000 |
Inari Medical | 1,300 |
Twist Bioscience | 919 |
GoodRx Holdings | 694 |
Amicus Therapeutics | 517 |
Denali Therapeutics | 445 |
ADMA News
- 2 months ago - ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 4 months ago - ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® - GlobeNewsWire
- 4 months ago - ADMA Biologics to Participate in the Raymond James Institutional Investor Conference - GlobeNewsWire
- 5 months ago - ADMA Biologics Announces CFO Transition - GlobeNewsWire
- 5 months ago - ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 5 months ago - ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics - GlobeNewsWire